All News

2057 articles, sorted by publication time.

Clinical Trials · eu

Intranasal mRNA therapy ETH47 lowers rhinovirus load; benefits for asthma symptoms remain to be verified

A 50-person viral challenge trial showed that a single intranasal dose of ETH47 could suppress rhinovirus load, but respiratory symptoms, the study’s primary measure, have so far shown only a trend toward numerical improvement. A clinical evidence hurdle remains between strengthening local antiviral defenses and reducing asthma exacerbations.

Medical Testing · us

Distinguishing Infections Through the Immune Response: Access MeMed BV Receives FDA Clearance, Providing Clues in as Little as 15 Minutes

Bacterial and viral infections often have similar symptoms, but antibiotic decisions cannot always wait. This blood test brings host-response analysis to existing laboratory instruments and is intended for patients as young as 90 days old. Beyond speed, the key is how it is integrated with clinical judgment.